The Vanguard Group Discloses Position in Life Science REIT plc

The Vanguard Group, Inc. submitted a Form 8.3, revealing interests in Life Science REIT plc. The disclosure, in compliance with Rule 8.3 of the Takeover Code, indicates a 1% stake, totaling 3,484,461 ordinary shares. This position was valid as of June 25, 2025.

No additional disclosures were made regarding other parties to the offer, and no dealings, options, or derivatives positions were indicated. Furthermore, there are no agreements or arrangements affecting voting rights or future acquisitions of relevant securities.

The statement emphasizes no indemnity or other incentives related to Life Science REIT, with the necessary disclosures to a Regulatory Information Service in accordance with the Code. For further inquiries, Shawn Acker is the point of contact.